Table 2.
Complementation of cephalosporin sensitivity of the ΔprkC2 mutant in MM9YE supplemented with ribose (0.2%), Em, and rhamnose (1%)
| Antibiotic | Median fold sensitization* | 
|
|---|---|---|
| Vector control† | prkC+ complementation‡ | |
| Cefuroxime | 192 | 6 | 
| Ceftazidime | 128 | 4 | 
| Cefotaxime | 768 | 5 | 
| Ceftriaxone | 128 | 2 | 
*Paired MIC determinations for the indicated strains were made in five or six independent experiments; the median fold sensitization (calculated as indicated) is reported. Values from the individual experiments are available in SI.
†Calculated as MIC (wild type + vector)/MIC (ΔprkC2 + vector). Vector was pCJK96.
‡Calculated as MIC (wild type + vector)/MIC (ΔprkC2 + prkC). Vector was pCJK96, and prkC expression plasmid was pCJK104.